| 1 |
33168727 | REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. | 2020 Nov 17 |
1 |
| 2 |
30867794 | Therapeutic efficacy of intra-tumor AvidinOX and low systemic dose biotinylated cetuximab, with and without cisplatin, in an orthotopic model of head and neck cancer. | 2019 Mar |
1 |
| 3 |
28057599 | Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition. | 2017 Mar |
1 |
| 4 |
26019260 | Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice. | 2015 Jul |
1 |
| 5 |
24571982 | Effects of four chemotherapeutic agents, bleomycin, etoposide, cisplatin, and cyclophosphamide, on DNA damage and telomeres in a mouse spermatogonial cell line. | 2014 Apr |
1 |
| 6 |
25387467 | Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response. | 2014 Nov 12 |
2 |
| 7 |
23784839 | UV and genotoxic stress induce ATR relocalization in mouse spermatocytes. | 2013 |
1 |
| 8 |
21593482 | DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress. | 2011 Sep |
3 |
| 9 |
19738461 | Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1. | 2009 Nov |
1 |
| 10 |
18162465 | ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. | 2008 Mar 7 |
1 |
| 11 |
18927497 | Protective role of Puralpha to cisplatin. | 2008 Dec |
1 |